These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5929267)

  • 21. Lipase activity in ethionine pancreatic lesions.
    Brulina A; Boccato P; Galzigna L
    Acta Vitaminol Enzymol; 1972; 26(5):163-70. PubMed ID: 4679520
    [No Abstract]   [Full Text] [Related]  

  • 22. Synthetic peptides in the diagnosis of exocrine pancreatic insufficiency in animals.
    Imondi AR; Stradley RP; Wolgemuth R
    Gut; 1972 Sep; 13(9):726-31. PubMed ID: 4639406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of sodium bicarbonate and pancreatin on the absorption of vitamin B12 and fat in pancreatic insufficiency.
    VEEGER W; ABELS J; HELLEMANS N; NIEWEG HO
    N Engl J Med; 1962 Dec; 267():1341-4. PubMed ID: 13996533
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of d-1-ethionine on electrolyte secretion of the dog pancreas.
    Feldman M; Dreiling DA; Paulino-Netto A; Schaffner F; Janowitz HD
    Am J Physiol; 1963 Nov; 205(5):878-84. PubMed ID: 5877417
    [No Abstract]   [Full Text] [Related]  

  • 25. Yarrowia lipolytica Lipase 2 Is Stable and Highly Active in Test Meals and Increases Fat Absorption in an Animal Model of Pancreatic Exocrine Insufficiency.
    Aloulou A; Schué M; Puccinelli D; Milano S; Delchambre C; Leblond Y; Laugier R; Carrière F
    Gastroenterology; 2015 Dec; 149(7):1910-1919.e5. PubMed ID: 26327131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular changes accompanying the degenerative and regenerative phase of ethionine-induced pancreatic damage in the rat.
    WACHSTEIN M; MEISEL E
    Lab Invest; 1953; 2(4):253-65. PubMed ID: 13070538
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of pancreatin therapy on fat absorption and nitrogen retention in children with fibrocystic disease of the pancreas.
    HARRIS R; NORMAN AP; PAYNE WW
    Arch Dis Child; 1955 Oct; 30(153):424-7. PubMed ID: 13269191
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical evaluation of iron metabolism in pancreatic disease.
    Miyamori A; Takebe T; Yamagata S
    Tohoku J Exp Med; 1976; 118 Suppl():159-72. PubMed ID: 964020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [In search for pancreas inhibitors. Preliminary report].
    Alvizouri M
    Gac Med Mex; 1967 Jun; 97(6):719-28. PubMed ID: 5611982
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of ethanol on iron tolerance and endogenous serum iron in liver cirrhosis.
    Hoenig V; Brodanová M; Kordac V
    Scand J Gastroenterol; 1968; 3(3):334-8. PubMed ID: 5708106
    [No Abstract]   [Full Text] [Related]  

  • 31. [Dose-dependent effect of pancreatin replacement upon the pancreatic function in the period after pancreatic surgery].
    Farkas G; Leindler L; Mihalovits G
    Magy Seb; 2001 Dec; 54(6):347-50. PubMed ID: 11816130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pancreas and iron absorption.
    Kahn IJ
    Gastroenterology; 1966 Nov; 51(5):736-8. PubMed ID: 5926944
    [No Abstract]   [Full Text] [Related]  

  • 33. Equal effectiveness of L and D-ethionine in producing tissue damage in rats and mice.
    WACHSTEIN M; MEISEL E
    Proc Soc Exp Biol Med; 1953 Jan; 82(1):70-2. PubMed ID: 13037806
    [No Abstract]   [Full Text] [Related]  

  • 34. Does the pancreas influence iron absorption? A critical review of information to date.
    Murray MJ; Stein N
    Gastroenterology; 1966 Nov; 51(5):694-700. PubMed ID: 5332921
    [No Abstract]   [Full Text] [Related]  

  • 35. CHANGES IN AFFINITY OF LIVER FOR IRON AND LOSS OF LIVER IRON DURING PROLONGED ETHIONINE ADMINISTRATION.
    KLAVINS JV; KINNEY T; KAUFMAN N
    Am J Pathol; 1965 Jun; 46(6):969-76. PubMed ID: 14328024
    [No Abstract]   [Full Text] [Related]  

  • 36. THE INTRACELLULAR DISTRIBUTION OF IRON IN THE LIVERS OF ETHIONINE-TREATED RATS.
    JOHNSTON WW; KAUFMAN N; KINNEY TD; KLAVINS JV
    Lab Invest; 1965 Mar; 14():258-63. PubMed ID: 14283727
    [No Abstract]   [Full Text] [Related]  

  • 37. Cellular proliferation in the canine pancreas after d,l-ethionine dosage as detected by double immunohistochemical labelling.
    Govendir M; Canfield PJ; Church DB
    Exp Toxicol Pathol; 2003 Sep; 55(2-3):129-35. PubMed ID: 14620533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SEQUENCE OF DEPOSITION AND LOSS OF STAINABLE IRON IN THE LIVER DURING ETHIONINE ADMINISTRATION.
    KAUFMAN N; KLAVINS JV; KINNEY TD
    Am J Pathol; 1964 Dec; 45(6):905-15. PubMed ID: 14234477
    [No Abstract]   [Full Text] [Related]  

  • 39. [Modification of exocrine pancreatic function by oral administration of pancreatic enzymes].
    Herzfeld U; Kaess H
    Med Welt; 1973 Jan; 24(2):51-3. PubMed ID: 4803293
    [No Abstract]   [Full Text] [Related]  

  • 40. [Role of the pancreas in duodeno-jejunal iron absorption].
    Plessier J; Najean Y; Economopoulos P
    Rev Med Chir Mal Foie; 1967 Jun; 42(3):115-28. PubMed ID: 5621261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.